Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership
Friday, May 03, 2013
Partners will co-develop a genomic test to help guide treatment decisions for patients diagnosed with leukemia, lymphoma or myeloma.
Plexpress Announces ADME-Tox Programs for CRO’s
Friday, May 03, 2013
EMA and FDA recommend mRNA testing in ADME-Tox studies for superior sensitivity.
Turn out the Light: 'Switch' Determines Cancer Cell Fate
Friday, May 03, 2013
Like picking a career or a movie, cells have to make decisions – and cancer results from cells making wrong decisions.
Study Establishes Basis for Genomic Classification of Endometrial Cancers
Thursday, May 02, 2013
Proper categorization is important for choosing the best treatment.
Physicists, Biologists Unite to Expose How Cancer Spreads
Thursday, May 02, 2013
New study has found that cancer cells that can break out of a tumor are more aggressive and nimble than nonmalignant cells.
Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate
Wednesday, May 01, 2013
Research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms.
Arrowhead Prices $36 Million Private Offering
Wednesday, May 01, 2013
Arrowhead Research Corporation announced that it has priced a private offering with gross proceeds expected to be $36 million. The offering was priced at $1.83 per common share.
Teva Expands Management Team
Wednesday, May 01, 2013
Teva Pharmaceutical Industries Ltd. announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer.
FORMA Therapeutics and Celgene Corporation Establish Broad Strategic Collaboration
Wednesday, May 01, 2013
FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets.
|
|
|
| << | 2 3 4 5 6 7 8 | >> | | Showing Results 41 - 50 of 2375 |
|
|
